INFORMATIVE SITE.

remdesivir tablet Remdesivir is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. As of  2020, remdesivir is under investigation as a specific treatment for COVID-19 and has been authorized by the U.S. Food and Drug Administration (FDA) under Emergency Use Authorization (EUA) for emergency treatment for those hospitalized with severe disease. It may have an effect on the time it takes to recover from the disease. It is given by injection into a vein. SECTIONS Dosing & Uses ADULT PEDIATRIC Dosage Forms & Strengths injection, lyophilized powder for reconstitution 100mg/vial injection, solution 100mg/20mL (5mg/mL) Coronavirus Disease 2019 (COVID-19) (Investigational) May 1, 2020: The FDA has granted an emergency use authorization (EUA) for remdesivir to treat hospitalized adults and children with suspected or laboratory-confirmed SARS CoV-2 infection and severe COVID-19 disease EUA facilitates broader use of remdesivir,